EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

The Role of Therapeutic Plasma Exchange in Treating Hypertriglyceridemia‐Associated Acute Pancreatitis: A Real‐World Effectiveness Analysis Using the TriNetX Global Collaborative Network

Nisar Amin, Tim Carll, Harleen Chela, Amir Kamran, Geoffrey D. Wool, Ebubekir Daglilar

Journal of Clinical Apheresis · 2025-08 · 40 (4)

DOI: 10.1002/jca.70053 ↗
AstrattDettalji biblijografiċi

Astratt

ABSTRACT Therapeutic plasma exchange (TPE) is used to lower triglyceride levels in patients with severe hypertriglyceridemia‐associated acute pancreatitis (HTG‐AP). However, evidence supporting the effectiveness of TPE in preventing end‐organ damage remains limited. This retrospective cohort study was conducted using the TriNetX database to evaluate adults with acute pancreatitis, triglyceride levels > 1000 mg/dL, and “worrisome criteria”, defined as clinical indicators of disease severity such as fever, leukocytosis, elevated lactate, or signs of shock. Patients receiving TPE within 3 days of diagnosis were compared with patients with no TPE within 30 days. Outcomes included triglyceride reduction to < 500 mg/dL, ICU admission, end‐organ damage, and mortality. Of 14 188 patients with HTG‐AP, 3% ( n = 419) received TPE; 97% ( n = 13 237) were treated without TPE. After 1:1 propensity‐score matching, 2 well‐matched, 412‐patient cohorts were created. More patients in the TPE cohort had a reduction in triglyceride levels to < 500 mg/dL at 1 week (81% vs. 40%, p < 0.001) and 1 month (86% vs. 48%, p < 0.001). However, the TPE cohort also had higher ICU admission rates (39% vs. 19%, p < 0.001). No significant differences in organ failure rates were observed at 1 week (4.4% vs. 3.3%, p = 0.47) or 1 month (5.8% vs. 5.0%, p = 0.71). Similarly, 30‐day (4.4% vs. 6.3%, p = 0.21) and 3‐month (5.3% vs. 7.8%, p = 0.16) all‐cause mortality were comparable between the cohorts. In patients with HTG‐AP, use of TPE within 3 days of diagnosis reduces triglyceride levels effectively but does not significantly reduce the risk of end‐organ damage or mortality. TPE is associated with increased ICU care requirements, which may reflect protocolized ICU admission.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →